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Purpose or Objective: Whole brain radiotherapy (WBRT) has 
been the treatment of choice for patients with brain 
metastases. However, change/decline of neurocognitive 
functions (NCFs) resulting from impaired hippocampal 
neurogenesis might occur after WBRT. It is reported that 
hippocampal sparing would provide the preservation of NCFs. 
Our study aims to investigate the correlations between 
hippocampal dosimetry and neurocognitive outcomes in 
patients receiving hippocampal sparing during WBRT (HS-
WBRT). 
 
Material and Methods: Fifty prospectively recruited cancer 
patients underwent HS-WBRT for therapeutic or prophylactic 
purposes. Before receiving HS-WBRT, all participants 
received a battery of baseline neurocognitive assessment, 
including memory, executive functions and psychomotor 
speed. The follow-up neurocognitive assessment at 4 months 
after HS-WBRT was also performed. To deliver HS-WBRT, 
Volumetric Modulated Arc Therapy (VMAT) with two full arcs 
and two non-coplanar partial arcs was employed. For each 
treatment planning, dose volume histograms were generated 
for left hippocampus, right hippocampus, and the composite 
hippocampal structure respectively. Biologically equivalent 
doses in 2-Gy fractions (EQD2) assuming an alpha/beta ratio 
of 2 Gy were computed. To perform analyses addressing the 
correlation between hippocampal dosimetry and the change 
in NCF scores, pre- and post-HS-WBRT neurocognitive 
assessments were available in 32 patients. 
 
Results: NCF scores were quite stable before and after HS-
WBRT regarding hippocampus-dependent memory. For verbal 
memory, the corresponding EQD2 values of 0%, 10%, 50%, 80% 
irradiating the composite hippocampal structure with 
<12.60Gy, <8.81Gy, <7.45Gy and <5.83Gy respectively were 
significantly associated with neurocognitive preservation 
indicated by the immediate recall of Word List Test of 
Wechsler Memory Scale-III. According to logistic regression 
analyses, it showed that dosimetric parameters specific to 
left hippocampus exerted an influence on immediate recall 
of verbal memory (adjusted odds ratio, 4.08; p-value, 0.042, 
predicting patients’ neurocognitive decline after HS-WBRT). 
 
Conclusion: Functional preservation by hippocampal sparing 
during WBRT is indeed achieved in our study. Providing that 
modern VMAT techniques can reduce the dose irradiating 
bilateral hippocampi below dosimetric threshold, patients 
should be recruited in prospective trials of hippocampal 
sparing during cranial irradiation to accomplish 
neurocognitive preservation while maintaining intracranial 
control. 
 
OC-0350  
Post-radiation neuronal depletion in hippocampus 
measured by in-vivo magnetic resonance spectroscopy 
P. Pospisil1, T. Kazda
1Masaryk Memorial Cancer Institute, Radiation Oncology, 
Brno, Czech Republic 
1, R. Jancalek2, P. Slampa1 
2St. Anne’s University Hospital Brno, Department of 
Neurosurgery, Brno, Czech Republic 
 
Purpose or Objective: Ongoing clinical trials are evaluating 
advantage of hippocampal avoiding whole brain radiotherapy 
(WBRT), however, further basic research focusing on in-vivo 
description of radiation injury processes is still needed. Using 
magnetic resonance spectroscopy (MRS), it is possible to 
measure specific metabolite concentrations in any region of 
interest in the brain. N-acetylaspartate (NAA) represents a 
marker of viable neurons. To describe hypothesized post- 
WBRT neuronal depletion in hippocampus, we prospectively 
measured changes in NAA concentrations 4 months after 
WBRT. 
 
Material and Methods: Patients referred for WBRT with 
favorable prognosis estimated by graded prognostic 
assessment and without MRI hippocampal pathology were 
eligible for study enrollment. Before standard WBRT (two-
dimensional planning, 2 laterolateral 6 megavoltage fields, 
dose 10x3.0 Gy delivered by linear accelerator), hippocampal 
spectroscopy was performed using GE Medical Systems 
Discovery MR 750 3T. Region of interest was placed through 
the whole temporal lobi with the voxel layer position 
adjusted based on the localization of hippocampi. Specialized 
software was utilized for measurement of absolute NAA 
concentration in voxels within right, left and both 
hippocampi. The controle MRS with the same setup 
parameters was performed 4 months after the end of course 
of WBRT. Wilcoxon’s signed rank test was employed for 
calculation of NAA concentration changes. 
 
Results: Thirty-five patients (68% mens, mean age 59.5) were 
enrolled and underwent baseline MRS while only 18 (51%) of 
them finished the whole protocol with control measurement 
(15 died before and 2 refused). The most common primary 
cancer was lung (44%), kidney (20%) and breast (15%). On 
average, 9 voxels were analyzed per right and left 
hippocampus. The mean NAA concentration pre- and post-
WBRT was 8.47 [mM] and 7.43 [mM] for the right and 8.80 
[mM] and 8.04 [mM] for the left hippocampus, respectively. 
The statistically significant decrease was observed in the 
right (-11.4%; 95% confidence interval -6.9 to -15.9; 
p=0.0003) as well as in the left (-8.5%; 95% confidence 
interval -2.9 to -14.0; p=0.0034) hippocampus. 
 
Conclusion: Hippocampal MR spectroscopy is feasible and 
sensitive method for non-invasive measurement of brain radio 
injury. In our study, we observed correlation between left 
hippocampal N-acetylaspartate concentration and verbal 
memory decline with smaller effect of right hippocampus. 
Robust analysis of pre-irradiation imaging studies may 
provide valuable predictive biomarkers for decision making 
for the best radiotherapy approach in the treatment of brain 
metastases. 
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Purpose or Objective: To establish dose–volume effect 
correlations for late small bowel toxicities in patients treated 
for locally advanced cervical cancer with concomitant 
chemoradiation followed by MRI-guided adaptive 
brachytherapy. 
 
Material and Methods: In a cohort of patients treated in 
curative intent and followed prospectively, those who had 
completed the treatment one year before were retained for 
this study. The small bowel loops were delineated during the 
planning process, but no specific dose constraint was applied. 
The dosimetric data, converted in 2 Gy equivalent (α/β=3) 
were confronted to the occurrence of small bowel events: 
diarrhea, pain, flatulence, bleeding, obstruction, and fistula. 
Patients were followed every 3 months for the first year then 
every 6 months, for 3 years, then annually. Late morbidity 
was defined over the threshold of 90 days from treatment 
initiation and assessed using the CTC-AE 3.0. Patients who 
experienced recurrences were censored from the date of 
their relapse. Dose-effect relationships were assessed using 
